Skip to main content
. 2019 Oct 1;97(2):235–245. doi: 10.1111/cge.13640

Table 1.

Overview of likely disease‐causing FBN1 and FBN2 variants in gnomAD

FBN1 exons 23‐34 FBN1 all exons FBN2 exons 23‐34 FBN2 all exons
Nonsense and frameshift (category I) 2 8 5 29a (27)
Splicing (category II) 0 26 (10) 0 36 (25)
In‐frame indels (category III) 1 9 (6) 0 8 (5)
Disulfide bonds (category IV) 1 8 4 36 (31)
Calcium binding (category IV) 4 12 (12) 6 (5) 49 (23)
HGMD 2019.1/ClinVar 2019.5 (category V)b 1 4 (3) 0 0

Sensu stricto selected sequence

variants (categories I‐V) / (Prevalence)

9:138 632 /

(0.65:10 000)

67:138 632 /

(4.83:10 000)

39:138 632 /

(2.81:10 000)

158:138 632 /

(11.40:10 000)

Sensu lato selected sequence variants (category VI)c 566 (40) 880 (162) 321 (71) 1.999 (301)
All variants (categories I‐VI) / (Prevalence)

575:138 632 /

(41.48:10 000)

947:138 632 /

(68.31:10 000)

360:138 632 /

(25.97:10 000)

2,157:138 632 /

(155.59:10 000)

All individuals in gnomAD (exomes and genomes) 138 632

Note: Numbers indicate the total number of variants, while numbers in parenthesis indicate the number of unique variants.

Abbreviations: gnomAD, Genome Aggregation Consortium; HGMD, Human Gene Mutation Database; indel, small insertion/deletion.

a

Nonsense/frameshift variants were counted regardless of their position in FBN2.

b

Only sequence variants not already included in categories I‐IV and passing manual evaluation were counted.

c

Sequence variants predicted as "damaging" or "deleterious" by all of the six used in silico prediction tools (FATHMM, FATHMM‐MKL, MutationAsessor, MutationTaster, PolyPhen2, SIFT) not contained in I‐V were counted; see also Supporting Information Table S1.